评估[具体药物或治疗方法未提及]在阿片类物质使用障碍中的治疗潜力和毒性。 - Suppr

Assessing the therapeutic potential and toxicity of in opioid use disorder.

作者信息

Sharma Abhisheak, McCurdy Christopher R

机构信息

Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL, USA.

Translational Drug Development Core, Clinical and Translational Sciences Institute, University of Florida, Gainesville, FL, USA.

出版信息

Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):255-257. doi: 10.1080/17425255.2021.1853706. Epub 2020 Dec 11.

DOI:10.1080/17425255.2021.1853706

PMID:33213215

Abstract

摘要

相似文献

Assessing the therapeutic potential and toxicity of in opioid use disorder.

Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):255-257. doi: 10.1080/17425255.2021.1853706. Epub 2020 Dec 11.

Update on the Pharmacology and Legal Status of Kratom.

J Am Osteopath Assoc. 2016 Dec 1;116(12):802-809. doi: 10.7556/jaoa.2016.156.

Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.

J Ethnopharmacol. 2020 Mar 1;249:112462. doi: 10.1016/j.jep.2019.112462. Epub 2019 Dec 7.

Kratom (Mitragyna speciosa): Friend or Foe?

Prim Care Companion CNS Disord. 2020 Jan 30;22(1):19nr02507. doi: 10.4088/PCC.19nr02507.

Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?

Curr Drug Targets. 2019;20(2):166-172. doi: 10.2174/1389450118666170425154120.

Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.

Drug Alcohol Depend. 2020 Mar 1;208:107849. doi: 10.1016/j.drugalcdep.2020.107849. Epub 2020 Feb 3.

Kratom: Substance of Abuse or Therapeutic Plant?

Psychiatr Clin North Am. 2022 Sep;45(3):415-430. doi: 10.1016/j.psc.2022.04.002. Epub 2022 Jul 31.

Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users.

J Psychoactive Drugs. 2018 Jul-Aug;50(3):266-274. doi: 10.1080/02791072.2018.1443234. Epub 2018 Mar 20.

A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.

J Psychoactive Drugs. 2020 Nov-Dec;52(5):447-452. doi: 10.1080/02791072.2020.1773586. Epub 2020 Jun 17.

Kratom: a primer for pain physicians.

Curr Opin Anaesthesiol. 2024 Oct 1;37(5):575-580. doi: 10.1097/ACO.0000000000001413. Epub 2024 Jul 8.

引用本文的文献

Kratom safety and toxicology in the public health context: research needs to better inform regulation.

Front Pharmacol. 2024 Jun 3;15:1403140. doi: 10.3389/fphar.2024.1403140. eCollection 2024.

Biocompatibility and sub-chronic toxicity studies of phlorotannin/polycaprolactone coated trachea tube for advancing medical device applications.

Sci Rep. 2024 Feb 16;14(1):3945. doi: 10.1038/s41598-024-54684-8.

Kratom withdrawal: Discussions and conclusions of a scientific expert forum.

Drug Alcohol Depend Rep. 2023 Mar 15;7:100142. doi: 10.1016/j.dadr.2023.100142. eCollection 2023 Jun.

Kratom's Emergence and Persistence Within the US Polydrug Epidemic.

Curr Addict Rep. 2023;10(2):262-271. doi: 10.1007/s40429-023-00476-5. Epub 2023 Apr 18.

Kratom Alkaloids: A Blueprint?

ACS Chem Neurosci. 2023 Jan 18;14(2):195-197. doi: 10.1021/acschemneuro.2c00704. Epub 2023 Jan 3.

Variations in mitragynine content in the naturally growing Kratom () population of Thailand.

Front Plant Sci. 2022 Oct 27;13:1028547. doi: 10.3389/fpls.2022.1028547. eCollection 2022.

Respiratory effects of oral mitragynine and oxycodone in a rodent model.

Psychopharmacology (Berl). 2022 Dec;239(12):3793-3804. doi: 10.1007/s00213-022-06244-z. Epub 2022 Oct 29.

Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance.

PLoS One. 2022 Apr 26;17(4):e0259326. doi: 10.1371/journal.pone.0259326. eCollection 2022.

Kratom Abuse Potential 2021: An Updated Eight Factor Analysis.

Front Pharmacol. 2022 Jan 28;12:775073. doi: 10.3389/fphar.2021.775073. eCollection 2021.

How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data.

Subst Abus. 2022;43(1):865-877. doi: 10.1080/08897077.2021.2007517.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Assessing the therapeutic potential and toxicity of in opioid use disorder.

Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):255-257. doi: 10.1080/17425255.2021.1853706. Epub 2020 Dec 11.

Update on the Pharmacology and Legal Status of Kratom.

J Am Osteopath Assoc. 2016 Dec 1;116(12):802-809. doi: 10.7556/jaoa.2016.156.

Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.

J Ethnopharmacol. 2020 Mar 1;249:112462. doi: 10.1016/j.jep.2019.112462. Epub 2019 Dec 7.

Kratom (Mitragyna speciosa): Friend or Foe?

Prim Care Companion CNS Disord. 2020 Jan 30;22(1):19nr02507. doi: 10.4088/PCC.19nr02507.

Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?

Curr Drug Targets. 2019;20(2):166-172. doi: 10.2174/1389450118666170425154120.

Kratom (Mitragyna speciosa): User demographics, use patterns, and implications for the opioid epidemic.

Drug Alcohol Depend. 2020 Mar 1;208:107849. doi: 10.1016/j.drugalcdep.2020.107849. Epub 2020 Feb 3.

Kratom: Substance of Abuse or Therapeutic Plant?

Psychiatr Clin North Am. 2022 Sep;45(3):415-430. doi: 10.1016/j.psc.2022.04.002. Epub 2022 Jul 31.

Severity of Pain and Sleep Problems during Kratom (Mitragyna speciosa Korth.) Cessation among Regular Kratom Users.

J Psychoactive Drugs. 2018 Jul-Aug;50(3):266-274. doi: 10.1080/02791072.2018.1443234. Epub 2018 Mar 20.

A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management.

J Psychoactive Drugs. 2020 Nov-Dec;52(5):447-452. doi: 10.1080/02791072.2020.1773586. Epub 2020 Jun 17.

Kratom: a primer for pain physicians.

Curr Opin Anaesthesiol. 2024 Oct 1;37(5):575-580. doi: 10.1097/ACO.0000000000001413. Epub 2024 Jul 8.

引用本文的文献

Kratom safety and toxicology in the public health context: research needs to better inform regulation.

Front Pharmacol. 2024 Jun 3;15:1403140. doi: 10.3389/fphar.2024.1403140. eCollection 2024.

Biocompatibility and sub-chronic toxicity studies of phlorotannin/polycaprolactone coated trachea tube for advancing medical device applications.

Sci Rep. 2024 Feb 16;14(1):3945. doi: 10.1038/s41598-024-54684-8.

Kratom withdrawal: Discussions and conclusions of a scientific expert forum.

Drug Alcohol Depend Rep. 2023 Mar 15;7:100142. doi: 10.1016/j.dadr.2023.100142. eCollection 2023 Jun.

Kratom's Emergence and Persistence Within the US Polydrug Epidemic.

Curr Addict Rep. 2023;10(2):262-271. doi: 10.1007/s40429-023-00476-5. Epub 2023 Apr 18.

Kratom Alkaloids: A Blueprint?

ACS Chem Neurosci. 2023 Jan 18;14(2):195-197. doi: 10.1021/acschemneuro.2c00704. Epub 2023 Jan 3.

Variations in mitragynine content in the naturally growing Kratom () population of Thailand.

Front Plant Sci. 2022 Oct 27;13:1028547. doi: 10.3389/fpls.2022.1028547. eCollection 2022.

Respiratory effects of oral mitragynine and oxycodone in a rodent model.

Psychopharmacology (Berl). 2022 Dec;239(12):3793-3804. doi: 10.1007/s00213-022-06244-z. Epub 2022 Oct 29.

Plant growth and phytoactive alkaloid synthesis in kratom [Mitragyna speciosa (Korth.)] in response to varying radiance.

PLoS One. 2022 Apr 26;17(4):e0259326. doi: 10.1371/journal.pone.0259326. eCollection 2022.

Kratom Abuse Potential 2021: An Updated Eight Factor Analysis.

Front Pharmacol. 2022 Jan 28;12:775073. doi: 10.3389/fphar.2021.775073. eCollection 2021.

How essential is kratom availability and use during COVID-19? Use pattern analysis based on survey and social media data.

Subst Abus. 2022;43(1):865-877. doi: 10.1080/08897077.2021.2007517.

Assessing the therapeutic potential and toxicity of in opioid use disorder.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Assessing the therapeutic potential and toxicity of in opioid use disorder.

作者信息

机构信息

出版信息

相似文献

引用本文的文献